Biotechnology

Renexxion Ireland Ltd. Announces a Licensing and Collaboration Agreement with Dr. Falk Pharma GmbH

ROSCREA, Ireland and FREIBURG, Germany, Oct. 5, 2021 /PRNewswire/ -- Renexxion Ireland Ltd., a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need gastrointestinal ("GI") disorders, announced today that it has entered into a Licensing and C...

2021-10-05 20:10 2544

NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference

SHELTON, Conn., Oct. 5, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, presented an update of its Pan-Coronavirus COVID-19 Drug Development Program at t...

2021-10-05 18:45 10749

GenScript establishes Korean legal entity and accelerates sales activities

SEOUL, South Korea, Oct. 5, 2021 /PRNewswire/ -- GenScript, a global biotech company, recently completed the establishment of a legal entity called "GenScript Biotech Korea Ltd." and began to strengthen its sales activities in Korea in earnest. GenScript Biotech Korea Ltd. has built a nest at IK...

2021-10-05 09:00 4553

Himalaya Therapeutics Announces Submission in Mainland China of IND Applications for its CAB-AXL-ADC to treat sarcomas and NSCLC, its CAB-ROR2-ADC to treat melanoma and NSCLC

SHANGHAI and SAN DIEGO, Oct. 5, 2021 /PRNewswire/ -- Himalaya Therapeutics  ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China, of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, whi...

2021-10-05 01:08 1436

RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients

TEL AVIV, Israel and RALEIGH, N.C., Oct. 4, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported new data from the opaganib global Phase 2/3 study in hospitalized patien...

2021-10-04 21:24 9555

Debiopharm Encourages Breakthrough Cancer Research in Japan Through its Competitive JCA Mauvernay Award

LAUSANNE, Switzerland, Oct. 4, 2021 /PRNewswire/ -- Debiopharm ( www.debiopharm.com ), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categ...

2021-10-04 15:00 1279

World's Leading Neuroscientists Unveil Research on COVID-19's Impact on the Brain, Understanding Migraine Pathophysiology, Solving the Mystery of Sleep, Biomarkers in Traumatic Brain Injury and More at 25th Biennial World Congress of Neurology from October 3-7

LONDON, Oct. 2, 2021 /PRNewswire/ -- The impact COVID-19 has on the brain, understanding migraine pathophysiology, solving the mystery of sleep by "Lighting Up the Brain," blood biomarkers for traumatic brain injury and more groundbreaking research will be unveiled by the world's leading neurosci...

2021-10-02 12:10 4423

CStone presents ARROW study data for GAVRETO® (pralsetinib) in Chinese patients with RET-mutant medullary thyroid cancer (MTC) for the first time in a late breaking oral abstract session at the 90th Annual Meeting of the American Thyroid Association 2021

* Primary efficacy results showed GAVRETO had robust and durable anti-tumor activity in the Chinese patients with advanced or metastatic RET-mutant medullary thyroid cancer (MTC), with a confirmed objective response rate (ORR) of 73.1%. And the 9-month duration of response (DOR) rate was 100% ...

2021-10-02 08:30 8897

TurtleTree Launches New Research and Development Facility in Greater Sacramento

WEST SACRAMENTO, Calif., Oct. 2, 2021 /PRNewswire/ -- TurtleTree has officially opened its new R&D facility inCalifornia's state capital. Located in West Sacramento, this 24,000-square-foot building will house a world-class research hub showcasing the company's extensive array of innovations and ...

2021-10-01 22:00 2764

Medidata Veterans Rama Kondru and Sastry Chilukuri Named co-CEOs

SINGAPORE and SYDNEY, Oct. 1, 2021 /PRNewswire/ -- Medidata, a Dassault Systèmes company, recently namedRama Kondru and Sastry Chilukuri co-CEOs. Both are Medidata veteran...

2021-10-01 09:00 2690

CBMG Holdings Completes $120 Million in Series A Funding, Accelerating Development of CAR-T Therapy Pipelines and R&D for Innovative Solid Tumor Therapies

HONG KONG, Sept. 30, 2021 /PRNewswire/ -- CBMG Holdings (or the "Company"), a Cayman Island biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer and degenerative diseases, today announced the closing of a $120 million Series A investment, led by As...

2021-09-30 22:06 2800

Cynata Enters into a New Strategic Partnership with Fujifilm

Key highlights * Cynata and Fujifilm have entered into a new strategic partnership which includes detailed and agreed core terms for Fujifilm to provide clinical and commercial manufacturing services for, and supply of, Cynata's Cymerus™ therapeutic mesenchymal stem cell (MSC) products * Cyn...

2021-09-30 21:30 2202

Benson Hill Completes Business Combination with Star Peak Corp II

Creates a leading publicly traded sustainable food technology company developing better tasting, more nutritious, sustainable and affordable ingredient and food choices CropOS® technology platform empowers the Company to bring seed to fork innovations to fuel the rapidly growing plant-based food...

2021-09-30 20:01 22197

Broncus Completed the First-in-man Clinical Trial of Its Targeted Lung Denervation Radiofrequency Ablation System

HONG KONG, Sept. 30, 2021 /PRNewswire/ -- Broncus Holding Corporation ("Broncus" or the "Company") is pleased to announce that it has completed the first-in-man clinical trial of its Targeted Lung Denervation (TLD) radiofrequency ablation system, which is expected to benefit patients with chroni...

2021-09-30 19:40 1992

Zantrene® kills melanoma cancer cells that overproduce FTO

* Zantrene® at low concentrations kills high FTO producing melanoma cancer cells * Sensitivity to Zantrene® correlates with FTO levels, where high FTO producing cells show up to 60x greater sensitivity than low FTO producing cells * Results are highly supportive of future clinical trials in ...

2021-09-30 11:58 9914

Recbio and Rhegen Signed an mRNA Vaccine Cooperation Agreement

TAIZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (referred to as "Recbio") and Shenzhen Rhegen Biotechnology Co., Ltd. (referred to as "Rhegen Bio") recently signed a joint venture agreement to establish a joint venture company "Wuhan Rhecogen Biotechnology Co., ...

2021-09-29 19:37 2342

Hong Kong's first biotech firm to cultivate microalgae for its abundant plant-based protein for consumer application

HONG KONG, Sept. 29, 2021 /PRNewswire/ -- The bioscience start-up, Geb Impact Technology Company Limited has developed an advanced technology to rapidly cultivate clear water single-celled microalgae. Microalgae are the abundant and sustainable source of high-quality plant-based protein, fit for ...

2021-09-29 18:26 1632

Reversing Asia Pacific's biodiversity and nature loss crisis could result in US$4.3 trillion worth of nature-positive business opportunities

* A new study by AlphaBeta, Temasek and the World Economic Forum estimates that 63 percent ofAsia Pacific's GDP, US$19.5 trillion, is threatened by biodiversity and nature loss * It also identifies 59 nature-positive business opportunities that can unlock US$4.3 trillion in business value and ...

2021-09-29 15:36 2644

Molecular Stethoscope, Inc. Announces Presentation at 16th Annual Sequencing to Function: Analysis and Applications for the Future Meeting

Presentation highlights a path forward to lead the development of the Company's clinical-grade Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform PALO ALTO, Calif., Sept. 29, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a Precision Medicine biotechnology compa...

2021-09-29 15:00 1420

Innovent Releases Preliminary Results of the Phase Ia Dose-Escalation study of IBI315 (Anti-Her2/PD-1 Bispecific Antibody) in Patients with Advanced Solid Tumors at CSCO Annual Meeting 2021

SAN FRANCISCO and SUZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-09-29 08:00 2832
1 ... 9899100101102103104 ... 167